Alliqua BioMedical Inc (ALQA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3423
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protection and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. It operates through its GMP manufacturing facility in Langhorne. Alliqua BioMedical is headquartered in Langhorne, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alliqua Enters Into Distribution Agreement With Sorbion 11
Licensing Agreements 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 14
Equity Offering 15
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 15
Alliqua Completes Private Placement Of Shares For US$15 Million 16
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 17
Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 18
Alliqua BioMedical Inc – Key Competitors 19
Alliqua BioMedical Inc – Key Employees 20
Alliqua BioMedical Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 22
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 25
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 26
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 27
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliqua Enters Into Distribution Agreement With Sorbion 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 14
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 15
Alliqua Completes Private Placement Of Shares For US$15 Million 16
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 17
Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 18
Alliqua BioMedical Inc, Key Competitors 19
Alliqua BioMedical Inc, Key Employees 20
Alliqua BioMedical Inc, Subsidiaries 21

List of Figures
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Alliqua BioMedical Inc (ALQA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genentech, Inc.:企業の戦略・SWOT・財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kopin Corp (KOPN):企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • Salling Group AS:企業の戦略的SWOT分析
    Salling Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Electrovaya Inc. (EFL)-エネルギー分野:企業M&A・提携分析
    Summary Electrovaya Inc. (Electrovaya) is a vertically integrated energy storage solutions company which designs, develops, manufactures, and markets power technology products. Its offerings include lithium ion super polymer batteries, battery systems, and battery related products and accessories. T …
  • Estee Lauder Companies Inc:企業の戦略・SWOT・財務情報
    Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Wright Medical Group NV (WMGI):医療機器:M&Aディール及び事業提携情報
    Summary Wright Medical Group NV (Wright) is a medical device company which focuses on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and hand; foot and ankle products. It a …
  • Sui Northern Gas Pipelines Ltd (SNGP):企業の財務・戦略的SWOT分析
    Sui Northern Gas Pipelines Ltd (SNGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Teekay Corp (TK):企業の財務・戦略的SWOT分析
    Teekay Corp (TK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Solar Alliance Energy Inc.:企業のM&A・事業提携・投資動向
    Solar Alliance Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solar Alliance Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Associated British Foods Plc:企業の戦略・SWOT・財務分析
    Associated British Foods Plc - Strategy, SWOT and Corporate Finance Report Summary Associated British Foods Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Austevoll Seafood Asa
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DePuy Synthes Inc:企業の戦略的SWOT分析
    DePuy Synthes Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Electrabel SA:企業の戦略的SWOT分析
    Electrabel SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Hargreaves Services Plc:企業の戦略・SWOT・財務情報
    Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ASML Holding N.V.:企業の戦略・SWOT・財務分析
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析
    Summary Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development …
  • Roche Diagnostics International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …
  • Arthur J. Gallagher & Co:戦略・SWOT・企業財務分析
    Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report Summary Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆